Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Rogier Klok"'
Autor:
Habib Bouzina, Göran Rådegran, Oisin Butler, Roger Hesselstrand, Clara Hjalmarsson, Katsiaryna Holl, Kjell Jansson, Rogier Klok, Stefan Söderberg, Barbro Kjellström
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 680-690 (2021)
Abstract Aims Low‐risk status in pulmonary arterial hypertension (PAH) predicts better survival. The present study aimed to describe changes in risk status and treatment approaches over multiple clinical assessments in PAH, taking age and comorbidi
Externí odkaz:
https://doaj.org/article/253a17a75ecb491b93069ff3c04c3861
Autor:
Clara Hjalmarsson, Oisin Butler, Roger Hesselstrand, Katsiaryna Holl, Kjell Jansson, Rogier Klok, Göran Rådegran, Stefan Söderberg, Barbro Kjellström
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Phosphodiesterase-5 inhibitors are commonly used in pulmonary arterial hypertension but, as suggested by the RESPITE study, phosphodiesterase-5 inhibitor therapy (mono-/combination) does not always have a satisfactory treatment effect. This study aim
Externí odkaz:
https://doaj.org/article/695b206b17b349f788ffcaaf509b1a4f
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e89415 (2014)
This work is the first attempt to quantify the overall effects of a 13-valent pneumococcal conjugate vaccine (PCV13) vaccination programme in the Dutch population taking into account all the direct and indirect effects of the vaccine on invasive pneu
Externí odkaz:
https://doaj.org/article/d5bcfe35ee0d41d1803f57e58ec517a1
Autor:
Kamlesh Khunti, Chantal Mathieu, Bart Torbeyns, Stefano Del Prato, Robert Heine, Helen Colhoun, Thomas Danne, Mette Due-Christensen, Katarina Eeg-Olofsson, Guy Fagherazzi, Robert Haustein, Rogier Klok, Fleur Levrat-Guillen, Massimo Massi Benedetti, Manel Mata, Jaivir Pall, Jeannette Soderberg, Ola Vedin, Petra Wilson
Publikováno v:
The Lancet Diabetes & Endocrinology. 11:70-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa9e5a7ec715840539b051e50eab40d3
https://doi.org/10.1016/s2213-8587(22)00386-2
https://doi.org/10.1016/s2213-8587(22)00386-2
Publikováno v:
Journal of the American College of Cardiology. 81:1916
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f304048e916cb46f06c845f75684eb99
https://doi.org/10.1016/s0735-1097(23)02360-4
https://doi.org/10.1016/s0735-1097(23)02360-4
Autor:
Stefan Söderberg, Clara Hjalmarsson, Oisin Butler, Roger Hesselstrand, Katsiaryna Holl, Barbro Kjellström, Kjell Jansson, Rogier Klok, Göran Rådegran
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
Phosphodiesterase-5 inhibitors are commonly used in pulmonary arterial hypertension but, as suggested by the RESPITE study, phosphodiesterase-5 inhibitor therapy (mono-/combination) does not always have a satisfactory treatment effect. This study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eae3b3b5434906bca0d7d27a7af6811
http://europepmc.org/articles/PMC7534092
http://europepmc.org/articles/PMC7534092
Autor:
Roger Hesselstrand, Rogier Klok, Kjell Jansson, Stefan Söderberg, Oisin Butler, Göran Rådegran, Katsiaryna Holl, Habib Bouzina, Clara Hjalmarsson, Barbro Kjellström
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 1, Pp 680-690 (2021)
ESC Heart Failure, Vol 8, Iss 1, Pp 680-690 (2021)
Aims Low-risk status in pulmonary arterial hypertension (PAH) predicts better survival. The present study aimed to describe changes in risk status and treatment approaches over multiple clinical assessments in PAH, taking age and comorbidity burden i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e199209fc1264f7f74b177261d303f6e
https://pubmed.ncbi.nlm.nih.gov/33305545
https://pubmed.ncbi.nlm.nih.gov/33305545
Publikováno v:
Helicobacter, 9(1), 87-91
University of Groningen
University of Groningen
BACKGROUND: Eradication of Helicobacter pylori prevents recurrence of peptic ulcer. In pharmacoeconomic analyses it is often presumed that after successful eradication no more gastrointestinal drugs are used. We investigated this presumed positive mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bb1499931dd68b7b9852383236d0ab63
https://research.rug.nl/en/publications/72e99510-d556-4b76-abaa-15ec351ca3e7
https://research.rug.nl/en/publications/72e99510-d556-4b76-abaa-15ec351ca3e7
Publikováno v:
Pharmaceutisch Weekblad, 139(49), 1638-1642. Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)
University of Groningen
University of Groningen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e540da8ed19d2a598cf112478fa3bfda
https://research.rug.nl/en/publications/c43f1d5b-5127-4f24-9065-277ddb0f4ff8
https://research.rug.nl/en/publications/c43f1d5b-5127-4f24-9065-277ddb0f4ff8
Autor:
Rogier Klok, Maarten Postma
Publikováno v:
University of Groningen
Expert Reviews Pharmacoeconomics Outcomes research, 4(6), 599-601
Expert Reviews Pharmacoeconomics Outcomes research, 4(6), 599-601
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::88dcc9e42b7790542efdf96fb51923c4
https://research.rug.nl/en/publications/d691a156-b53a-4fce-94e0-49ebb79ef5e7
https://research.rug.nl/en/publications/d691a156-b53a-4fce-94e0-49ebb79ef5e7